Science Explorer Back to mapMap
Discussion
Company · Eugene · United States

Marker Gene Technologies (United States)

markergene.comROR OpenAlex
Research works
45
▲ 102% vs 2018-21
Citations
1k
22.8 per fractional work
Top-10% rate
12.8%
all institutions 10.0%
Open access
25%
world 40%
International
15%
world 18%
Marker Gene Technologies (United States)

Not ranked overall: Marker Gene Technologies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Marker Gene Technologies (United States) work in?

In all years, 51% of research at Marker Gene Technologies (United States) is in Life Sciences, 25% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (39%), Medicine (25%), Engineering (8%). It does 2.6× the world's share of Life Sciences.

Life Sciences: 23 fractional works · 50.9% of its workBiochemistry, Genetics and Molecular Biology: 17 fractional works · 38.7% of its workMolecular Biology: 13 fractional works · 28.2% of its workBiophysics: 2 fractional works · 4.7% of its workGenetics: 1 fractional works · 1.5% of its workCancer Research: 1 fractional works · 1.4% of its workCell Biology: 0 fractional works · 1.1% of its workBiotechnology: 0 fractional works · 0.8% of its workClinical Biochemistry: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.4% of its workImmunology and Microbiology: 3 fractional works · 7.0% of its workImmunology: 3 fractional works · 7.0% of its workNeuroscience: 1 fractional works · 2.9% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.5% of its workNeurology: 1 fractional works · 1.2% of its workCognitive Neuroscience: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 2.2% of its workAnimal Science and Zoology: 1 fractional works · 1.3% of its workFood Science: 0 fractional works · 0.4% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workHealth Sciences: 11 fractional works · 24.9% of its workMedicine: 11 fractional works · 24.7% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 5.7% of its workPhysiology: 2 fractional works · 3.8% of its workOncology: 1 fractional works · 2.8% of its workEpidemiology: 1 fractional works · 2.2% of its workHepatology: 1 fractional works · 1.8% of its workImmunology and Allergy: 1 fractional works · 1.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.4% of its workSurgery: 0 fractional works · 1.1% of its workPathology and Forensic Medicine: 0 fractional works · 1.0% of its workGenetics: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.7% of its workInfectious Diseases: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.2% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.8% of its workNursing: 0 fractional works · 0.2% of its workPhysical Sciences: 10 fractional works · 23.3% of its workEngineering: 4 fractional works · 8.1% of its workBiomedical Engineering: 2 fractional works · 4.1% of its workElectrical and Electronic Engineering: 1 fractional works · 1.4% of its workControl and Systems Engineering: 0 fractional works · 0.7% of its workMechanical Engineering: 0 fractional works · 0.7% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.7% of its workComputational Mechanics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 4 fractional works · 8.0% of its workOrganic Chemistry: 2 fractional works · 3.9% of its workSpectroscopy: 2 fractional works · 3.5% of its workInorganic Chemistry: 0 fractional works · 0.4% of its workElectrochemistry: 0 fractional works · 0.2% of its workMaterials Science: 2 fractional works · 3.4% of its workMaterials Chemistry: 1 fractional works · 3.0% of its workBiomaterials: 0 fractional works · 0.4% of its workChemical Engineering: 1 fractional works · 1.9% of its workBioengineering: 1 fractional works · 1.9% of its workEnvironmental Science: 0 fractional works · 1.0% of its workEcology: 0 fractional works · 0.4% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.6% of its workAtmospheric Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.4% of its workApplied Mathematics: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.9% of its workBusiness, Management and Accounting: 0 fractional works · 0.8% of its workManagement of Technology and Innovation: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.1% of its workALL ITS WORKMarker GeneTechnologies…45fractional works, all years
Life Sciences51%Physical Sciences23%Health Sciences25%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1738.7%
    2. Immunology and Microbiology37.0%
    3. Neuroscience12.9%
    4. Agricultural and Biological Sciences12.2%
    5. Pharmacology, Toxicology and Pharmaceutics00.2%
    1. Medicine1124.7%
    2. Nursing00.2%
    1. Engineering48.1%
    2. Chemistry48.0%
    3. Materials Science23.4%
    4. Chemical Engineering11.9%
    5. Environmental Science01.0%
    6. Earth and Planetary Sciences00.6%
    7. Mathematics00.4%
    1. Business, Management and Accounting00.8%
    2. Decision Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.82× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.20× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.65× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 4.72× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.12× its world share, 0 worksChemistryEngineering: 1.55× its world share, 1 worksEngineeringEnvironmental Science: 0.33× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.95× its world share, 0 worksMaterials ScienceMathematics: 2.83× its world share, 0 worksMathematicsMedicine: 1.78× its world share, 2 worksMedicineBusiness, Management and Accounting: 2.06× its world share, 0 worksBusiness, Management…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.7×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics4.72×0 works
  2. Biochemistry, Genetics and Molecular Biology3.20×1 works
  3. Mathematics2.83×0 works
  4. Chemistry2.12×0 works
  5. Business, Management and Accounting2.06×0 works
  6. Medicine1.78×2 works
  7. Immunology and Microbiology1.65×0 works
  8. Engineering1.55×1 works
  9. Materials Science0.95×0 works
  10. Agricultural and Biological Sciences0.82×0 works
  11. Environmental Science0.33×0 works

Who are the top researchers at Marker Gene Technologies (United States)?

Ranked on the quality score, John Joseph Naleway lead among researchers whose main affiliation is Marker Gene Technologies (United States).

  1. 1 John Joseph Naleway United States · #3,094,430 worldwide 487 citations · 30 works
All ranked researchers at Marker Gene Technologies (United States)

What are the most cited papers from Marker Gene Technologies (United States)?

The most cited paper from Marker Gene Technologies (United States) is "Heterogeneous expression of the triggering receptor expressed on myeloid cells‐2 on adult murine microglia" (Christoph D. Schmid, Lauren N. Sautkulis, Patria E. Danielson et al., 2002), with 357 citations. Next come "The spectrum ofWRNmutations in Werner syndrome patients" (228) and "Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease" (182).

Most cited papers
#PaperReleasedCitations
1 Heterogeneous expression of the triggering receptor expressed on myeloid cells‐2 on adult murine microglia Christoph D. Schmid, Lauren N. Sautkulis, Patria E. Danielson et al. · Journal of Neurochemistry Open access Dec 2002 357
2 The spectrum ofWRNmutations in Werner syndrome patients Shurong Huang et al. · Human Mutation Open access 3 May 2006 228
3 Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease Claudia Cicognola, Gunnar Brinkmalm, Jessica Wahlgren et al. · Acta Neuropathologica Open access 13 Dec 2018 182
4 Bacillus and Other Spore-Forming Genera: Variations in Responses and Mechanisms for Survival Aleksandra Checinska, Andrzej J. Paszczynski, Malcolm B. Burbank · Annual Review of Food Science and Technology Review 24 Feb 2015 115
5 Searching for Interferon-Induced Genes That Inhibit Hepatitis B Virus Replication in Transgenic Mouse Hepatocytes Stefan F. Wieland, Raquel González de Vega, Rolf Müller et al. · Journal of Virology Open access 26 Dec 2002 102
All 70 most cited papers, with filters and sorting

Which keywords describe research at Marker Gene Technologies (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Biosensors, Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Gene Expression, Antibody Engineering, Fc Receptors and Immune Response.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Biosensors4▲ 14×4 topics
  2. Glycosylation3▲ 33×3 topics
  3. Monoclonal Antibodies3▲ 48×3 topics
  4. Therapeutic Antibodies3▲ 52×2 topics
  5. Gene Expression3▲ 9.4×6 topics
  6. Inflammation3▲ 2.5×14 topics
  7. Epidemiology2▲ 1.29×12 topics
  8. Antibody Engineering2▲ 49×1 topic
  9. Cancer2▲ 3.5×8 topics
  10. Fc Receptors2▲ 49×1 topic
  11. Immune Response2▲ 7.6×7 topics
  12. Machine Learning2▲ 2.2×4 topics
  13. Bioimaging2▲ 17×3 topics
  14. Drug Discovery2▲ 9.4×2 topics
  15. Bioimage Analysis2▲ 135×1 topic
  16. High-Content Screening2▲ 135×1 topic
  17. Imaging2▲ 10×2 topics
  18. Click Chemistry2▲ 43×1 topic
  19. Copper-Catalyzed Cycloaddition2▲ 103×1 topic
  20. Parkinson's Disease2▲ 15×2 topics
  21. Enzyme Replacement Therapy1▲ 117×1 topic
  22. Lysosomal Storage Disorders1▲ 162×1 topic
  23. Nanoparticles1▲ 2.4×3 topics
  24. Reactive Oxygen Species1▲ 6.5×3 topics
  25. Angiogenesis1▲ 7.2×3 topics
  26. High-Throughput Analysis1▲ 65×1 topic
  27. Protein Microarrays1▲ 150×1 topic
  28. Genetic Variation1▲ 8.6×4 topics
  29. Innate Immunity1▲ 7.9×4 topics
  30. Liver Disease1▲ 19×3 topics
  31. Metabolism1▲ 4.1×5 topics
  32. Self-Assembly1▲ 6.6×2 topics
  33. Antiviral Therapy1▲ 16×2 topics
  34. Gene Therapy1▲ 9.2×4 topics
  35. Lab-on-a-Chip1▲ 18×2 topics
  36. Bioluminescence1▲ 108×1 topic
  37. DNA nanotechnology1▲ 22×1 topic
  38. Neurodegenerative Diseases1▲ 11×3 topics
  39. Reporter Genes1▲ 108×1 topic
  40. aptamers1▲ 22×1 topic

Which research topics does Marker Gene Technologies (United States) publish most on?

By volume in 2022-now: Technology Assessment and Management, Porphyrin Metabolism and Disorders, MRI in cancer diagnosis and Kidney Stones and Urolithiasis Treatments.

Technology Assessment an…0Technology Assessment and Management: 0 fractional worksPorphyrin Metabolism and…0Porphyrin Metabolism and Disorders: 0 fractional worksMRI in cancer diagnosis: 0 fractional worksKidney Stones and Urolit…0Kidney Stones and Urolithiasis Treatments: 0 fractional worksSystems Engineering Meth…0Systems Engineering Methodologies and Applications: 0 fractional worksProduct Development and Customization: 0 fractional worksVanadium and Halogenation Chemistry: 0 fractional worksAlzheimer's disease rese…0Alzheimer's disease research and treatments: 0 fractional worksGas Dynamics and Kinetic Theory: 0 fractional worksGraphite, nuclear technology, radiation studies: 0 fractional works
Safety, Risk, Reliability and QualityMolecular BiologyRadiology, Nuclear Medicine and ImagingPulmonary and Respiratory Medicine6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Technology Assessment and Management Safety, Risk, Reliability and Quality 0 works
  2. 2 Porphyrin Metabolism and Disorders Molecular Biology 0 works
  3. 3 MRI in cancer diagnosis Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Kidney Stones and Urolithiasis Treatments Pulmonary and Respiratory Medicine 0 works
  5. 5 Systems Engineering Methodologies and Applications Control and Systems Engineering 0 works
  6. 6 Product Development and Customization Management of Technology and Innovation 0 works
  7. 7 Vanadium and Halogenation Chemistry Inorganic Chemistry 0 works
  8. 8 Alzheimer's disease research and treatments Physiology 0 works
  9. 9 Gas Dynamics and Kinetic Theory Applied Mathematics 0 works
  10. 10 Graphite, nuclear technology, radiation studies Materials Chemistry 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available25.2%not open74.8%

World: 40% of research is openly available.

with international co-authors14.8%domestic only85.2%

World: 18% is written across borders.

How has Marker Gene Technologies (United States)'s research output changed?

Output in 2022-2025 was 102% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Marker Gene Technologies (United States) as a percentage of every work published that year, 0.000029% in 2024.

still counting0.00010%0.00020%Marker Gene Technologies (United States)0.000020% in 2025200020102020

Fractional works of Marker Gene Technologies (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Eugene

All research institutions in Eugene

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Marker Gene Technologies (United States). Posts are plain text and can be reported.